PMID- 36111930 OWN - NLM STAT- MEDLINE DCOM- 20220920 LR - 20221216 IS - 2284-0729 (Electronic) IS - 1128-3602 (Linking) VI - 26 IP - 17 DP - 2022 Sep TI - Comparative analysis between mono approach and multi approaches in managing T2DM: a survey-based study. PG - 6290-6299 LID - 29653 [pii] LID - 10.26355/eurrev_202209_29653 [doi] AB - OBJECTIVE: The aim of the study was to analytically compare the therapeutic effect of the addition of diet modification and regular exercise to oral agents. MATERIALS AND METHODS: This cross-sectional study surveyed 1248 participants via online and offline modes by employing a questionnaire about an individual's management of diabetes. Group 1 patients follow Single Approach Management for Type 2 Diabetes Mellitus (T2DM), while Group 2 and Group 3 patients follow Multi-Approach Management for T2DM. Based on the answers, the participants were classified into three groups. The diagnostic criteria of Diabetes Mellitus Type-2 in this study were done by determining morning Fasting Blood Sugar (FBS) and glycated Hemoglobin (HbA1c). RESULTS: The current study found 656 single oral agent users and 592 combination regimens users among all the study participants. The study also found that, among all participants, 511 patients were on mild to moderate diet modification while 325 patients were on moderate to severe diet modification. The study also noted that 232 males and 215 females took Complementary and Alternative Medicines (CAM). Of 447 patients, 12 showed menstrual abnormalities (2.6%), and 18 had mild diarrhoea (4%). The study also found that there is a vital significance of lowering FBS and HbA1c with the management strategies (p=0.000). The study showed a strong association between group 3 and improved FBS and HbA1c (p=0.000). CONCLUSIONS: This study reveals that diet modification and regular exercise improve FBS and HbA1c levels significantly. Hence, diet modification and exercise can be added as adjuvants and should be incorporated into the management guidelines of T2DM. FAU - Alanazi, M AU - Alanazi M AD - Department of Clinical Pharmacy, Department of Pharmaceutical Chemistry, College of Pharmacy, University of Hail, Hail, Kingdom Saudi Arabia. drunnisa.aziz10@gmail.com. FAU - Unnisa, A AU - Unnisa A FAU - Patel, R D AU - Patel RD FAU - Alanazi, J AU - Alanazi J FAU - Khalid, M AU - Khalid M FAU - Ahmad, S AU - Ahmad S FAU - Jandrajupalli, S B AU - Jandrajupalli SB FAU - Hussain, T AU - Hussain T FAU - Abobaker, S H AU - Abobaker SH FAU - Chandolu, S AU - Chandolu S LA - eng PT - Journal Article PL - Italy TA - Eur Rev Med Pharmacol Sci JT - European review for medical and pharmacological sciences JID - 9717360 RN - 0 (Blood Glucose) RN - 0 (Glycated Hemoglobin A) SB - IM MH - Blood Glucose/analysis MH - Cross-Sectional Studies MH - *Diabetes Mellitus, Type 2/diagnosis/therapy MH - Female MH - Glycated Hemoglobin/analysis MH - Humans MH - Male MH - Surveys and Questionnaires EDAT- 2022/09/17 06:00 MHDA- 2022/09/21 06:00 CRDT- 2022/09/16 09:13 PHST- 2022/09/16 09:13 [entrez] PHST- 2022/09/17 06:00 [pubmed] PHST- 2022/09/21 06:00 [medline] AID - 29653 [pii] AID - 10.26355/eurrev_202209_29653 [doi] PST - ppublish SO - Eur Rev Med Pharmacol Sci. 2022 Sep;26(17):6290-6299. doi: 10.26355/eurrev_202209_29653.